Another A+ job from our friends at HealthNewsReview.org.
“The researcher who discusses the test, and who is the senior author of the New England Journal of Medicine study that sparked the coverage, is listed on a patent related to CHIP and serves as a consultant to a testing company. Many other authors on this study, and sources for the Times story, have similar conflicts of interest.”
“The existence of such commercial relationships shouldn’t diminish the excitement surrounding the science. Experts I reached out to all agreed that this is important and groundbreaking research. Some optimism is warranted.
But is it possible that financial interests might subtly bias the perspective of the CHIP researchers — contributing to an enthusiasm that stretches past what the current evidence can support?”